David Shaw’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.29M Buy
66,000
+37,800
+134% +$3.65M ﹤0.01% 2112
2026
Q2
$2.21M Buy
28,200
+7,300
+35% +$498K ﹤0.01% 3117
2026
Q1
$1.35M Buy
+20,900
New +$1.47M ﹤0.01% 3205
2015
Q2
– Sell
-53,000
Closed -$757K – 3783
2015
Q1
$757K Buy
+53,000
New +$764K ﹤0.01% 2766

Other funds holding HALO

David Shaw's HALO Position: Q3 2026 in Review

David Shaw increased its Halozyme (HALO) stake by 68% in Q3 2026, buying an estimated $132M and bringing the position to 3,373,506 shares worth $372M. The position accounts for 0.18% of the portfolio, ranked #110.

David Shaw first reported a position in HALO in Q1 2014 and has held it in 48 quarters since. 777 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • David Shaw held 3,373,506 shares of Halozyme worth $372M as of Q3 2026.
  • David Shaw bought 1,367,027 Halozyme shares in Q3 2026, an estimated $132M.
  • Halozyme made up 0.18% of David Shaw's portfolio in Q3 2026, its #110 holding.
  • David Shaw first reported a position in Halozyme in Q1 2014 and has held it in 48 quarters since.
  • 777 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.